BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24423297)

  • 1. A high aldosterone to renin ratio is associated with high serum parathyroid hormone concentrations in the general population.
    Fischer E; Hannemann A; Rettig R; Lieb W; Nauck M; Pallauf A; Bidlingmaier M; Beuschlein F; Wallaschofski H; Reincke M
    J Clin Endocrinol Metab; 2014 Mar; 99(3):965-71. PubMed ID: 24423297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reference intervals for aldosterone, renin, and the aldosterone-to-renin ratio in the population-based Study of Health in Pomerania (SHIP-1).
    Hannemann A; Friedrich N; Lüdemann J; Völzke H; Rettig R; Peters J; Reincke M; Döring A; Nauck M; Wallaschofski H
    Horm Metab Res; 2010 Jun; 42(6):392-9. PubMed ID: 20157876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma aldosterone levels and aldosterone-to-renin ratios are associated with endothelial dysfunction in young to middle-aged subjects.
    Hannemann A; Wallaschofski H; Lüdemann J; Völzke H; Markus MR; Rettig R; Lendeckel U; Reincke M; Felix SB; Empen K; Nauck M; Dörr M
    Atherosclerosis; 2011 Dec; 219(2):875-9. PubMed ID: 21968318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone and glomerular filtration--observations in the general population.
    Hannemann A; Rettig R; Dittmann K; Völzke H; Endlich K; Nauck M; Wallaschofski H
    BMC Nephrol; 2014 Mar; 15():44. PubMed ID: 24612948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality risk.
    Tomaschitz A; Pilz S; Rus-Machan J; Meinitzer A; Brandenburg VM; Scharnagl H; Kapl M; Grammer T; Ritz E; Horina JH; Kleber ME; Pieske B; Kraigher-Krainer E; Hartaigh BÓ; Toplak H; van Ballegooijen AJ; Amrein K; Fahrleitner-Pammer A; März W
    Int J Cardiol; 2015 Apr; 184():710-716. PubMed ID: 25777071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone-to-renin ratio as a predictor of stroke under conditions of high sodium intake: the Ohasama study.
    Satoh M; Kikuya M; Ohkubo T; Mori T; Metoki H; Hara A; Utsugi MT; Hashimoto T; Hirose T; Obara T; Inoue R; Asayama K; Kanno A; Totsune K; Hoshi H; Satoh H; Imai Y
    Am J Hypertens; 2012 Jul; 25(7):777-83. PubMed ID: 22476023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma renin activity and the aldosterone-to-renin ratio are associated with the development of chronic kidney disease: the Ohasama Study.
    Terata S; Kikuya M; Satoh M; Ohkubo T; Hashimoto T; Hara A; Hirose T; Obara T; Metoki H; Inoue R; Asayama K; Kanno A; Totsune K; Hoshi H; Satoh H; Sato H; Imai Y
    J Hypertens; 2012 Aug; 30(8):1632-8. PubMed ID: 22595958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry.
    Grotevendt A; Wallaschofski H; Reincke M; Adolf C; Quinkler M; Nauck M; Hoffmann W; Rettig R; Hannemann A
    Endocrine; 2017 Aug; 57(2):298-307. PubMed ID: 28638984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTH Is a Promising Auxiliary Index for the Clinical Diagnosis of Aldosterone-Producing Adenoma.
    Zhang LX; Gu WJ; Li YJ; Wang Y; Wang WB; Wang AP; Shen L; Zang L; Yang GQ; Lu ZH; Dou JT; Mu YM
    Am J Hypertens; 2016 May; 29(5):575-81. PubMed ID: 26304960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis.
    Brown J; de Boer IH; Robinson-Cohen C; Siscovick DS; Kestenbaum B; Allison M; Vaidya A
    J Clin Endocrinol Metab; 2015 Feb; 100(2):490-9. PubMed ID: 25412416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical validation and investigation on reference intervals of aldosterone and renin in Chinese Han population by using fully automated chemiluminescence immunoassays.
    Deng L; Xiong Z; Li H; Lei X; Cheng L
    Clin Biochem; 2018 Jun; 56():89-94. PubMed ID: 29684370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The simultaneous measurement of plasma-aldosterone- and -renin-concentration allows rapid classification of all disorders of the renin-aldosterone system.
    Diederich S; Mai K; Bähr V; Helffrich S; Pfeiffer A; Perschel FH
    Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):433-8. PubMed ID: 17647140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal osteoporosis is associated with elevated aldosterone/renin ratio.
    Shu X; Mei M; Ma L; Wang Z; Yang S; Hu J; Song Y; He W; Luo T; Cheng Q; Wang Y; Zhen Q; Li Q;
    J Hum Hypertens; 2018 Jul; 32(7):524-530. PubMed ID: 29789689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
    Verheyen N; Fahrleitner-Pammer A; Pieske B; Meinitzer A; Belyavskiy E; Wetzel J; Gaksch M; Grübler MR; Catena C; Sechi LA; Van Ballegooijen AJ; Brandenburg VM; Scharnagl H; Perl S; Brussee H; März W; Pilz S; Tomaschitz A
    J Hypertens; 2016 Sep; 34(9):1778-86. PubMed ID: 27379537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and depressed symptomatology: a cluster related to the activation of the renin-angiotensin-aldosterone system (RAAS). Findings from population based KORA F4 study.
    Häfner S; Baumert J; Emeny RT; Lacruz ME; Bidlingmaier M; Reincke M; Ladwig KH
    Psychoneuroendocrinology; 2013 Oct; 38(10):2065-74. PubMed ID: 23608138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of treatment with an angiotensin 2 receptor blocker and/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo-controlled trial.
    Bislev LS; Langagergaard Rødbro L; Nørgaard Bech J; Bjerregaard Pedersen E; Rolighed L; Sikjaer T; Rejnmark L
    Clin Endocrinol (Oxf); 2018 Nov; 89(5):656-666. PubMed ID: 29733445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin-aldosterone system (RAAS) and its relation with calcium homeostasis in male obesity.
    Ozata M; Durmus O; Yilmaz MI; Bolu E; Erdogan M; Ozdemir IC
    Med Sci Monit; 2002 Jun; 8(6):CR430-4. PubMed ID: 12070434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients.
    Rossi GP; Belfiore A; Bernini G; Fabris B; Caridi G; Ferri C; Giacchetti G; Letizia C; Maccario M; Mannelli M; Palumbo G; Patalano A; Rizzoni D; Rossi E; Pessina AC; Mantero F;
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2566-71. PubMed ID: 18445663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of obesity on the association of active renin and plasma aldosterone concentrations, and aldosterone-to-renin ratio with preeclampsia.
    Zitouni H; Raguema N; Gannoun MBA; Hebert-Stutter M; Zouari I; Maleh W; Faleh R; Letaifa DB; Almawi WY; Fournier T; Mahjoub T; Guibourdenche J
    Pregnancy Hypertens; 2018 Oct; 14():139-144. PubMed ID: 30527101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
    Brown JM; Williams JS; Luther JM; Garg R; Garza AE; Pojoga LH; Ruan DT; Williams GH; Adler GK; Vaidya A
    Hypertension; 2014 Feb; 63(2):273-80. PubMed ID: 24191286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.